October 7, 2015
Lilly Joins the Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study
Eli Lilly and Company and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, have announced financial commitment and continued scientific partnership to support the recently established Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study.